Biosimilar in lymphoma treatment
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
Hlavní autor: | Tanisha, Mehrin Haque |
---|---|
Další autoři: | Kabir, Eva Rahman |
Médium: | Diplomová práce |
Jazyk: | English |
Vydáno: |
Brac University
2021
|
Témata: | |
On-line přístup: | http://hdl.handle.net/10361/15533 |
Podobné jednotky
-
CAR-T cell Therapy in B-cell Lymphoma
Autor: Faruk, Asef
Vydáno: (2020) -
Targeted therapeutic options in the treatment of Breast Cancer
Autor: Alam, Kazi Tasnuva
Vydáno: (2022) -
Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
Autor: Tania, Umme
Vydáno: (2023) -
Biologics and Biosimilars as Treatment Options for Psoriasis
Autor: Moya, Amena Khatun
Vydáno: (2023) -
Concepts and challenges of biosimilars to mitigate the oncology drug expenses
Autor: Tania, Umme
Vydáno: (2021)